Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
Authors not listed
Shahid Beheshti University of Medical Sciences · 2005
Abstract
To compare the efficacy and safety results of intravitreal bevacizumab alone with bevacizumab + triamcinolone acetonide in neovascular AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2005). Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD. <em>Shahid Beheshti University of Medical Sciences</em>. https://clinicaltrials.gov/study/NCT00370370
Vancouver
Anonymous. Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD. Shahid Beheshti University of Medical Sciences. 2005.
BibTeX
@misc{anon2005Intrav,
title = {Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD},
author = {Anonymous},
journal = {Shahid Beheshti University of Medical Sciences},
year = {2005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Yonsei University 2007
Open access · US-GOV
Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone Acetonide Injection Versus Intravitreal Bevacizumab for Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 2005
Open access · US-GOV
Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
IRCCS San Raffaele 2011
Open access · US-GOV
Intravitreal Bevacizumab for the Treatment of Patients With Low Vision Due to Neovascular Age-related Macular Degeneration
Ophthalmology 2006
Citation only
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Ora Bio Ltd. 2009
Open access · US-GOV
A Randomized, Multi-Center, Double Blind, 3 Arm, Phase I/II Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)
Klinikum Bremen-Mitte, gGmbH 2008
Open access · US-GOV